Toradol (Ketorolac) in Breast Surgery to Reduce Pain & Opioid Use

Completed · Phase 1

Conditions studied: Breast Reduction, Breast Reconstruction

In brief

The purpose of this study is to investigate whether perioperative single-dose administration of ketorolac (Toradol) can reduce post-operative pain after breast surgery, thereby decreasing post-operative opioid use.

Key facts

Study ID

NCT04439396

Run by

Carilion Clinic

People needed

183

Starts

2020-06-22

Expected to finish

2023-01-30

Last updated by the study team

2023-02-10

Who can join

Age: 18 and older, up to 64. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Patient consents to study
• Adult females needing breast reconstruction or breast reduction (day surgeries)

You may not qualify if…

• Patients with known kidney disease
• Patient does not consent
• patients with history of bleeding disorder, peptic ulcer disease, renal disease, blood thinners use, bariatric surgery and any other contraindications of Toradol use
• patients currently taking aspirin
• pregnant women (not standard to operate on this population anyway)

Where it is running

• James T. Thompson — Roanoke, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.